Federal Register: December 30, 2002 (Volume 67, Number 250)
DOCID: FR Doc 02-32849
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Docket ID: [Docket No. 02N-0282]
ACTION: Agency information collection activities:
DOCUMENT ACTION: Notice.
Agency Information Collection Activities; Submission for OMB Review; Comment Request; Notice of Participation
DATES: Submit written comments on the collection of information by January 29, 2003.
The Food and Drug Administration (FDA) is announcing that the proposed collection of information listed below has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Submission for OMB review; comment request,
In compliance with 44 U.S.C. 3507, FDA has
submitted the following proposed collection of information to OMB for review and clearance.
Notice of Participation (OMB Control Number 09100191)Extension
The regulations in Sec. 12.45 (21 CFR 12.45), issued under section 701 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 371), sets forth the format and procedures for any interested person to file a petition to participate in a formal evidentiary hearing, either personally or through a representative. Section 12.45 requires that any person filing a notice of participation state their specific interest in the proceedings, including the specific issues of fact about which the person desires to be heard. Section 12.45 also requires that the notice include a statement that the person will present testimony at the hearing and will comply with specific requirements in 21 CFR 12.85, or in the case of a hearing before a Public Board of Inquiry (21 CFR 13.25), concerning disclosure of data and information by participants. In accordance with Sec. 12.45(e), the presiding officer may omit a participant's appearance. The presiding officer and other participants will use the collected information in a hearing to identify specific interests to be presented. This preliminary information serves to expedite the prehearing conference and commits participation. The respondents are individuals or households, State or local governments, notforprofit institutions, and businesses or other forprofit groups and institutions.
In the Federal Register of July 18, 2002 (67 FR 47387), FDA published a 60day notice requesting public comment on the information collection provisions. No comments were received.
FDA estimates the burden of this collection of information as follows:
Table 1.Estimated Annual Reporting Burden\1\ No. of Annual Frequency Total Annual Hours per 21 CFR Section Respondents per Response Responses Response Total Hours 12.45 340 1 340 3 1,020 \1\ There are no capital costs or operating and maintenance costs associated with this collection of information.
The agency bases this estimate on past notices filed in which each notice of participation took an estimated 3 hours to complete.
Dated: December 20, 2002.
Margaret M. Dotzel,
Assistant Commissioner for Policy.
[FR Doc. 0232849 Filed 122702; 8:45 am]
BILLING CODE 416001S
FOR FURTHER INFORMATION CONTACT
JonnaLynn P. Capezzuto, Office of Information Resources Management (HFA250), Food and Drug
Administration, 5600 Fishers Lane, Rockville, MD 20857, 3018274659.